MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC ARROW HEMODIALYSIS SET: 2-LUMEN 14 FR X 15 CM; CATHETER HEMODIALYTSIS NON IMP

Catalog Number	CS-22142-CF
Medical Device Problem Code	Patient-Device Incompatibility (2682)
Health Effect - Clinical Codes	Headache (1880); Muscle Weakness/Atrophy (1967); Pain (1994); Blurred Vision (2137)
Date of Event	06/19/2025
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Qn# (b)(4).
Event or Problem Description
It was reported "on (b)(6), he began to experience symptoms of malaise, loss of appetite, joint pain, and generalized weakness.Im dexamethasone + diclofenac was administered.Two days later, on (b)(6), he began to experience diplopia, headache, blurred vision, and gait disturbances, and his pruritus worsened.On (b)(6) 2025, he was admitted to the icu for monitoring due to the risk of ventilatory deterioration.On (b)(6) 2025, plasmapheresis was decided, leading to the installation of a right femoral mahurkar catheter.On (b)(6) 2025, the patient presented with a severely elevated leukocyte count and neutrophilia, in addition to compromised kidney function.To rule out an ongoing infection, blood cultures, a chest x-ray, and urinalysis + gram stain were ordered, and a temperature curve was monitored.Antibiotics were not started at this time due to hemodynamic stability." the patient's current condition is reported as "critical".
Additional Manufacturer Narrative
(b)(4).Complaint verification testing could not be performed as no sample was returned for analysis.Clinical and medical affairs (cma) was consulted as part of this investigation.Cma stated, "review of the reported event indicates that the patient was in a severely compromised clinical state at the time of catheter placement, including neurological deterioration, icu admission, and multiple risk factors for infection.Bloodstream infection was confirmed by cultures (mrsa and klebsiella) and classified as a hospital-acquired infection by the treating institution's infection control committee.Device ifu specifies that the preferred insertion site is the right internal jugular vein, with alternative options in jugular or subclavian locations if necessary.Femoral (inguinal) vein access, as used in this case, is not a recommended insertion site and carries a higher risk of contamination.The use of a non-recommended insertion site, combined with the patient's baseline condition and prolonged hospitalization, represents a significant confounding factor.Based on current evidence, this event does not indicate a device malfunction.The infection is most likely attributable to patient susceptibility and the use of a high-risk insertion site outside the ifu recommendations.Accordingly, the complaint is assessed as not device-related and more consistent with clinical practice deviation rather than a product performance issue." a device history record review was performed, and no relevant findings were identified.The instructions for use (ifu) provided with this kit states, "note: the preferred insertion site for central venous catheters is the right internal jugular vein.Other options include the right external jugular vein, left internal and external jugular vein.Subclavian access should be used only when no other upper extremity or chest-wall options are available." the complaint of catheter related infection could not be confirmed based on the information provided and consultation with clinical and medical affairs (cma).Although cma did confirm the report of a bloodstream infection based on the cultures that were tested from the patient, it could not be confirmed that the infection was the result of the catheter.Cma continued by stating, "the use of a non-recommended insertion site, combined with the patient's baseline condition and prolonged hospitalization, represents a significant confounding factor.Based on current evidence, this event does not indicate a device malfunction.The infection is most likely attributable to patient susceptibility and the use of a high-risk insertion site outside the ifu recommendations.Accordingly, the complaint is assessed as not device-related and more consistent with clinical practice deviation rather than a product performance issue." therefore, based on the information provided, the complaint of catheter related infection cannot be confirmed and the root cause cannot be determined as there are multiple confounding factors that may have resulted in this event.Teleflex will continue to monitor and trend for reports of this nature.
Event or Problem Description
It was reported "on (b)(6), he began to experience symptoms of malaise, loss of appetite, joint pain, and generalized weakness.Im dexamethasone + diclofenac was administered.Two days later, on (b)(6), he began to experience diplopia, headache, blurred vision, and gait disturbances, and his pruritus worsened.On (b)(6) 2025, he was admitted to the icu for monitoring due to the risk of ventilatory deterioration.On (b)(6) 2025, plasmapheresis was decided, leading to the installation of a right femoral mahurkar catheter.On (b)(6) 2025, the patient presented with a severely elevated leukocyte count and neutrophilia, in addition to compromised kidney function.To rule out an ongoing infection, blood cultures, a chest x-ray, and urinalysis + gram stain were ordered, and a temperature curve was monitored.Antibiotics were not started at this time due to hemodynamic stability." the patient's current condition is reported as "critical".

• Brand Name: ARROW HEMODIALYSIS SET: 2-LUMEN 14 FR X 15 CM
• Common Device Name: CATHETER HEMODIALYTSIS NON IMP
• Manufacturer (Section D): ARROW INTERNATIONAL LLC; morrisville NC
• Manufacturer (Section G): ARROW INTERNATIONAL CR, A.S.; jamska 2359/47; zdar nad sazavou 591 0 1; EZ 591 01
• Manufacturer Contact: katharine tarpley ; 3015 carrington mill blvd; morrisville, NC 27560
• MDR Report Key: 22726658
• Report Number: 3006425876-2025-00730
• Device Sequence Number: 12848174
• Product Code: MPB
• UDI-Device Identifier: 00801902100184
• UDI-Public: (01)00801902100184(11)240227(17)251128(10)71F24B1061(21)
• Combination Product (Y/N): N
• Initial Reporter Country: CO
• PMA/510(K) Number: K993933
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Foreign,User Facility
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 07/14/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Expiration Date: 11/28/2025
• Device Catalogue Number: CS-22142-CF
• Device Lot Number: 71F24B1061
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 07/14/2025
• Supplement Date Received by Manufacturer: 09/18/2025
• Initial Report FDA Received Date: 08/06/2025
• Supplement Report FDA Received Date: 09/19/2025
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 02/27/2024
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: NOT REPORTED; NOT REPORTED
• Patient Age: 57 YR
• Patient Sex: Male